Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. cut its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 7.1% during the 2nd quarter, HoldingsChannel reports. The fund owned 203,339 shares of the biopharmaceutical company’s stock after selling 15,510 shares during the period. Oppenheimer & Co. Inc.’s holdings in Bristol-Myers Squibb were worth $8,445,000 as of its most recent […]

Leave a Reply

Your email address will not be published.

Previous post Envestnet Asset Management Inc. Purchases 1,598,446 Shares of Dimensional U.S. Core Equity 2 ETF (NYSEARCA:DFAC)
Next post SPDR Dow Jones Industrial Average ETF Trust (NYSEARCA:DIA) Position Lowered by Oppenheimer & Co. Inc.